AU2002256694A1 - Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor - Google Patents

Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor

Info

Publication number
AU2002256694A1
AU2002256694A1 AU2002256694A AU2002256694A AU2002256694A1 AU 2002256694 A1 AU2002256694 A1 AU 2002256694A1 AU 2002256694 A AU2002256694 A AU 2002256694A AU 2002256694 A AU2002256694 A AU 2002256694A AU 2002256694 A1 AU2002256694 A1 AU 2002256694A1
Authority
AU
Australia
Prior art keywords
agonist
antagonist
diagnostic
screening
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002256694A
Inventor
Vincent Dupriez
Marc Parmentier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ogeda SA
Original Assignee
Euroscreen SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroscreen SA filed Critical Euroscreen SA
Publication of AU2002256694A1 publication Critical patent/AU2002256694A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
AU2002256694A 2001-03-20 2002-03-20 Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor Abandoned AU2002256694A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01870055 2001-03-20
EP01870055.9 2001-03-20
PCT/EP2002/003121 WO2002075273A2 (en) 2001-03-20 2002-03-20 Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor

Publications (1)

Publication Number Publication Date
AU2002256694A1 true AU2002256694A1 (en) 2002-10-03

Family

ID=8184941

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002256694A Abandoned AU2002256694A1 (en) 2001-03-20 2002-03-20 Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor

Country Status (2)

Country Link
AU (1) AU2002256694A1 (en)
WO (1) WO2002075273A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0228139D0 (en) * 2002-12-03 2003-01-08 Kozlova Zwinderman Olga Fungal biosensor for contaminant detection
US20100159449A1 (en) * 2006-05-26 2010-06-24 Noacell Science Co., Ltd. Continuous Assay Method for Measuring Receptor- and Ion Channel-Mediated Calcium Response and Subsequent Gene Expression
CA2589393C (en) 2006-06-13 2016-04-12 Euroscreen S.A. Ligand for g-protein coupled receptor gpr72 and uses thereof
EP1867994B1 (en) * 2006-06-13 2012-09-26 Euroscreen S.A. Ligand for G-protein coupled receptor GPR72 and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194406B1 (en) * 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
WO2000002045A2 (en) * 1998-07-06 2000-01-13 Euroscreen S.A. Bioluminescent assay for agonists or antagonists of a calcium-coupled receptor
ID28909A (en) * 1998-12-16 2001-07-12 Aventis Pharma Inc SERAGONIN RECEPTORS ANTAGONISTS WITH BIOLOGICAL DECREASE OF POLYMER AND ITS PRODUCTION METHOD

Also Published As

Publication number Publication date
WO2002075273A3 (en) 2003-08-28
WO2002075273A2 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
AU2001264713A1 (en) Methods and apparatus for preventing software modifications from invalidating previously passed integration tests
AU2002306629A1 (en) Method and apparatus for compounding individualized dosage forms
ZA200200596B (en) Method of treating certain cancers using an estrogen agonist/antagonist.
AU2001296650A1 (en) Seven-transmembrane (7tm) receptors and uses thereof
AU2002360203A1 (en) Device, system and method for image based size analysis
AU2002344483A1 (en) Image analysis supporting method, image analysis supporting program, and image analysis supporting device
AU2002238874A1 (en) Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors
AU2002362097A1 (en) Apparatus and methods for testing pain sensitivity
AU2003244375A1 (en) Method and device for automatic testing of an x-ray system
AU2003296726A1 (en) Method and device for radiographic imaging
EP1453503A4 (en) Ep4 receptor agonist, compositions and methods thereof
AU2002365655A1 (en) 5-ht7 receptor antagonists
AU2003289853A8 (en) Methods, device and instrument for detection of analytes
AU2002339855A1 (en) Method and apparatus for determining the health of a component using condition indicators
EP1376911A4 (en) Printing device, diagnosing method for printing device, and diagnosing program for printing device
AU2002256694A1 (en) Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor
AU2002359524A1 (en) P2x7 receptor antagonists
AU2003280675A1 (en) SELECTIVE HUMAN Beta3 ADRENALIN RECEPTOR AGONIST AGENT
AU2003222577A1 (en) Device and method for intermediation between service providers and their users
AU2003208193A1 (en) Device and method for determining parameters
AU2003244313A1 (en) Androgen receptor agonist
AU3476599A (en) Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
AU2003247052A1 (en) Mcp-1 receptor antagonists and method of use thereof
AU2003269680A1 (en) Method and device for determining traffic condition quantities
AU2002302774A1 (en) Macrophage receptor agonist or antagonist

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase